Todd Foley, Director at Repare Therapeutics Inc. (RPTX), sold 33,442 shares at $31.83 ($1.1M) on 2021-06-02, disclosed to the SEC on 2021-06-02.
Open-market sale of $1.1M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.67 | 7,377 | $241K | 22.2% |
| 2 | $32.67 | 7,377 | $241K | 22.2% |
| 3 | $32.50 | 6,671 | $217K | 20.0% |
| 4 | $32.50 | 6,671 | $217K | 20.0% |
| 5 | $31.83 | 2,608 | $83K | 7.6% |
| 6 | $31.83 | 2,608 |
| $83K |
| 7.6% |
| 7 | $32.42 | 130 | $4K | 0.4% |
| Total | $32.47 avg | 33,442 | $1.1M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |